ForSight VISION5 now Allergan

ForSight VISION5, now Allergan, is a small company based in Menlo Park, California, with a dedicated team of 3 employees. The company's annual revenue exceeds $10,000. ForSight VISION5 focuses on developing innovative, non-invasive products that aim to replace traditional eye drops and offer long-lasting treatment for a variety of anterior segment eye diseases. These include conditions like glaucoma, dry eye, and allergies. Their primary product candidate is the Helios(TM) insert, a groundbreaking non-invasive delivery system designed to continuously deliver medication to patients suffering from glaucoma and ocular hypertension. The company's commitment to non-invasive therapeutics sets it apart in the ophthalmology field. By creating alternative solutions to eye drops, ForSight VISION5 seeks to improve patient compliance and enhance the overall treatment experience for individuals managing chronic eye conditions. For more information about ForSight VISION5 and their innovative products, please visit their website at forsightvision5.com.